Logo

American Heart Association

  7
  0


Final ID: P-365

Prevalence of Hypertension in Minnesota Adults in 2023 Using Data from a Statewide Electronic Health Record Consortium

Abstract Body: Background: Data on prevalence of hypertension in the United States come primarily from in-person data collected by the National Health and Nutrition Examination Survey and self-reports in the Behavioral Risk Factor Surveillance Survey. Electronic phenotypic algorithms for hypertension that include diagnosis codes, blood pressure values, and antihypertensive treatment have been proposed and tested.
Objective: To describe prevalence of hypertension in Minnesota adults using data from a statewide electronic health record (EHR) consortium, the Minnesota EHR Consortium (MNEHRC).
Methods: Data from 11 health systems participating in the MNEHRC were standardized to a common data model allowing for distributed querying of EHR data. Data were de-duplicated using a one-way hash algorithm. Preliminary prevalence of hypertension in 2023 was estimated in Minnesota residents with > 1 encounter in the past 3 years who had >1 diagnosis of hypertension in the past 5 years. Medicaid insurance status was determined via linkage with state enrollment files. Residential addresses of patients were geocoded to census tracts and social vulnerability index (SVI) of census tracts was determined.
Results: Among 4,369,470 Minnesotan age 18 and older in 2023, 23.6% had hypertension based on >1 diagnosis code. Prevalence increased with age, was higher in men (26% vs. 22% in women), and adjusted for age and sex was highest in Black (30%) and Native American (27%) compared with White (23%) and Hispanic (21%) Minnesotans. Within each race/ethnic group, those insured by Medicaid had a higher adjusted hypertension prevalence than those with other insurance types. The prevalence of hypertension in census tracts with moderate to high SVI ranged from 3% to 43%, but on average was similar to the statewide prevalence of 24% (see image 1). Prevalence of hypertension in race/ethnicity, sex, and age subgroups in higher SVI census tracts was similar to the statewide prevalence in those subgroups.
Conclusions: The prevalence of hypertension in Minnesota was described in detail by demographic characteristics, geography and social vulnerability. Future work will expand the electronic hypertension phenotype and examine quality of care.
  • Margolis, Karen  ( HEALTHPARTNERS INSTITUTE , Minneapolis , Minnesota , United States )
  • Chamberlain, Alanna  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Drawz, Paul  ( University of Minnesota , Minneapolis , Minnesota , United States )
  • Author Disclosures:
    Karen Margolis: DO NOT have relevant financial relationships | Alanna Chamberlain: No Answer | Paul Drawz: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Poster Session 2

Friday, 09/06/2024 , 09:00AM - 10:30AM

Poster Session

More abstracts on this topic:
Global Statistics of Hypertensive Heart Disease and its Trend from 1990-2021: A Benchmarking Global Analysis from the Global Burden of Disease Study 2021

Rangani Ashutosh, Raj Rohan, Patel Khushbu, Desai Hardik, Lakkimsetti Mohit, Saravanabavanandan Ragavendar, Sonani Shivani, Dhillon Nimrat, Syed Saif, Yadav Ratan Pal, Shandilya Ashwinikumar, Amin Vishrant, Patel Juhi

Co-Created Intervention Promotes Uptake of Low Sodium Iodized Salt Substitute to Control Hypertension: Results from a Large Community-based Quasi-Experimental Study from India

Srinivasapura Venkateshmurthy Nikhil, Mohan Sailesh, Dubey Manisha, Sehgal Reena, Jarhyan Prashant, Khatkar Rajesh, Konkati Shiva Prasad, Sharma Manika, Ide Nicole, Prabhakaran Dorairaj

You have to be authorized to contact abstract author. Please, Login
Not Available